Senti Biosciences CFO Resigns, Transitions to Consultancy Role
TipRanks17:15 ET
Express News | Senti Biosciences Inc - on April 23, Deborah Knobelman, Co's Chief Financial Officer Notified Co of Decision to Resign From Company, Effective May 3
Reuters16:58 ET
Wolf Popper LLP Announces Investigations on Behalf of Investors in Materially Underperforming Special Purpose Acquisition Companies
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Wolf Popper LLP is investigating potential claims on behalf of investors in the following Special Purpose Acquisition Companies (SPAC). The stock prices of these companies,
GlobeNewswireApr 4 10:40 ET
Senti Biosciences 4Q Rev $0.00 >SNTI
Senti Biosciences 4Q Rev $0.00 >SNTI
Dow JonesMar 21 16:13 ET
Express News | Senti Biosciences Q4 2023 GAAP EPS $(0.42) Misses $(0.28) Estimate
Moomoo 24/7Mar 21 16:11 ET
Earnings Flash (SNTI) SENTI BIOSCIENCES Reports 2023 Revenue $2.6M
04:09 PM EDT, 03/21/2024 (MT Newswires) -- Earnings Flash (SNTI) SENTI BIOSCIENCES Reports 2023 Revenue $2.6M
MT NewswiresMar 21 16:09 ET
Press Release: Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights
SOUTH SAN FRANCISCO, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) ("Senti Bio" or the "Company"), a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today reported financial results for the fourth quarter and full year ended December 31, 2023.
Dow JonesMar 21 16:05 ET
Senti Biosciences Transfers Listing to Nasdaq Capital Market
TipRanksFeb 7 05:02 ET
Senti Biosciences Said Reducing Its Workforce By ~37% As Part Of Prioritizing Its Investment In Lead Clinical Program
Senti Biosciences, Inc. (NASDAQ:SNTI) ("Senti Bio" or the "Company"), a clinical stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platf
BenzingaJan 5 16:07 ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersKaruna Therapeutics (NASDAQ:KRTX) shares increased by 47.4% to $317.1 during Monday's pre-market session. The company's market cap stands at $11.9 billion. Universe Pharmaceuticals (NASDAQ:UPC)
BenzingaDec 25, 2023 08:05 ET
Why Is Blood Cancer Focused Senti Biosciences Stock Trading Higher Today?
Yahoo FinanceDec 22, 2023 12:12 ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersKaruna Therapeutics (NASDAQ:KRTX) stock moved upwards by 47.9% to $318.17 during Friday's pre-market session. The company's market cap stands at $12.0 billion. Senti Biosciences (NASDAQ:SNTI) s
BenzingaDec 22, 2023 08:07 ET
Senti Biosciences Announces FDA Clearance Of IND Application For SENTI-202 For The Treatment Of Relapsed Or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
Senti Biosciences Announces FDA Clearance Of IND Application For SENTI-202 For The Treatment Of Relapsed Or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
BenzingaDec 22, 2023 06:36 ET
Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
Senti Biosciences, Inc. (Nasdaq: SNTI) ("Senti Bio"), a clinical stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that it received clearance of its Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA) for SENTI-202, an off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cell therapy product candidate designed to selectively target and eliminate CD33 and/or FLT3 expressing hematologic malignancies while sparing healthy bone marrow cells.
Senti BiosciencesDec 22, 2023 00:00 ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersReshape Lifesciences (NASDAQ:RSLS) shares rose 58.2% to $0.4 during Tuesday's after-market session. The company's market cap stands at $5.2 million. NightHawk Biosciences (AMEX:NHWK) shares mov
BenzingaDec 12, 2023 16:31 ET
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersExicure (NASDAQ:XCUR) stock rose 54.5% to $0.66 during Thursday's after-market session. The market value of their outstanding shares is at $5.7 million. Aligos Therapeutics (NASDAQ:ALGS) stock
BenzingaDec 7, 2023 16:31 ET
Senti Biosciences GAAP EPS of -$0.83 Misses by $0.39, Revenue of $0.04M Misses by $0.66M
Seeking AlphaNov 14, 2023 02:32 ET
Senti Biosciences Q3 2023 EPS $(0.34) Up From $(0.38) YoY, Revenue $338K
Senti Biosciences Q3 2023 EPS $(0.34) Up From $(0.38) YoY, Revenue $338K
BenzingaNov 13, 2023 17:42 ET
Senti Biosciences 3Q Loss Cont Ops 83c/Shr
Senti Biosciences 3Q Loss Cont Ops 83c/Shr
Dow JonesNov 13, 2023 16:26 ET
Earnings Flash (SNTI) SENTI BIOSCIENCES Posts Q3 Revenue $338,000
04:16 PM EST, 11/13/2023 (MT Newswires) -- Earnings Flash (SNTI) SENTI BIOSCIENCES Posts Q3 Revenue $338,000
MT NewswiresNov 13, 2023 16:16 ET
No Data
No Data